Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET Company Participants Nathan Smith – Senior Vice President-Investor Relations and Treasury Paul Diaz – President and Chief Executive Officer Bryan Riggsbee – Chief Financial Officer Conference Call Participants Sung Ji Nam – BTIG Andrew Cooper – Raymond James Matt Sykes – Goldman Sachs Jack Meehan – Nephron Research Operator Greetings, and welcome to the Myriad Genetics Second Quarter 2021 Earnings Call. During the ...